Chondrocytes

ATLANTA, August 18, 2026 Alzamend Neuro, Inc. announced that pharmacokinetic imaging data from its Phase 1/2A clinical trial of...

HOUSTON, August 18, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing therapies based on fibroblast cells and fibroblast-derived materials,...